PHOTREXA Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Photrexa, and what generic alternatives are available?
Photrexa is a drug marketed by Glaukos and is included in one NDA.
The generic ingredient in PHOTREXA is riboflavin 5'-phosphate. There are ten drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the riboflavin 5'-phosphate profile page.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for PHOTREXA?
- What are the global sales for PHOTREXA?
- What is Average Wholesale Price for PHOTREXA?
Summary for PHOTREXA
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| Finished Product Suppliers / Packagers: | 1 |
| Raw Ingredient (Bulk) Api Vendors: | 76 |
| Clinical Trials: | 2 |
| Patent Applications: | 3,274 |
| Drug Prices: | Drug price information for PHOTREXA |
| DailyMed Link: | PHOTREXA at DailyMed |
Recent Clinical Trials for PHOTREXA
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| Glaukos Corporation | Phase 4 |
| Avedro, Inc. | Phase 4 |
| Comprehensive EyeCare of Central Ohio | Phase 4 |
US Patents and Regulatory Information for PHOTREXA
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Glaukos | PHOTREXA | riboflavin 5'-phosphate | SOLUTION/DROPS;OPHTHALMIC | 203324-001 | Apr 15, 2016 | RX | Yes | Yes | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Glaukos | PHOTREXA VISCOUS IN DEXTRAN 20% | riboflavin 5'-phosphate | SOLUTION/DROPS;OPHTHALMIC | 203324-002 | Apr 15, 2016 | RX | Yes | Yes | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
